Alps Advisors Inc Kura Oncology, Inc. Transaction History

Alps Advisors Inc

  • $14.5 Billion
  • Q2 2024

A detailed history of Alps Advisors Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 59,403 shares of KURA stock, worth $1.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59,403
Previous 53,700 10.62%
Holding current value
$1.16 Million
Previous $1.15 Million 6.81%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$17.53 - $22.98 $99,973 - $131,054
5,703 Added 10.62%
59,403 $1.22 Million
Q1 2024

May 14, 2024
BUY
$13.42 - $23.53 $43,225 - $75,790
3,221 Added 6.38%
53,700 $1.15 Million
Q4 2023

Feb 14, 2024
SELL
$7.58 - $14.38 $32,366 - $61,402
-4,270 Reduced 7.8%
50,479 $725,000
Q3 2023

Nov 14, 2023
BUY
$8.44 - $11.86 $37,482 - $52,670
4,441 Added 8.83%
54,749 $499,000
Q2 2023

Aug 14, 2023
BUY
$9.62 - $13.99 $50,168 - $72,957
5,215 Added 11.56%
50,308 $532,000
Q1 2023

May 10, 2023
SELL
$10.71 - $14.6 $12,637 - $17,228
-1,180 Reduced 2.55%
45,093 $551,000
Q4 2022

Feb 14, 2023
BUY
$11.23 - $16.9 $110,121 - $165,721
9,806 Added 26.89%
46,273 $574,000
Q3 2022

Nov 14, 2022
SELL
$12.01 - $19.45 $36,726 - $59,478
-3,058 Reduced 7.74%
36,467 $498,000
Q2 2022

Aug 11, 2022
BUY
$10.71 - $18.33 $423,312 - $724,493
39,525 New
39,525 $724,000
Q4 2020

Feb 03, 2021
SELL
$29.0 - $41.62 $2.08 Million - $2.99 Million
-71,775 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
$16.3 - $30.64 $42,575 - $80,031
-2,612 Reduced 3.51%
71,775 $2.2 Million
Q2 2020

Aug 05, 2020
SELL
$7.95 - $18.81 $63,623 - $150,536
-8,003 Reduced 9.71%
74,387 $1.21 Million
Q1 2020

May 06, 2020
SELL
$6.45 - $14.04 $61,926 - $134,798
-9,601 Reduced 10.44%
82,390 $820,000
Q4 2019

Feb 07, 2020
BUY
$12.97 - $15.94 $24,370 - $29,951
1,879 Added 2.09%
91,991 $1.27 Million
Q3 2019

Nov 04, 2019
BUY
$14.75 - $20.87 $150,214 - $212,540
10,184 Added 12.74%
90,112 $1.37 Million
Q2 2019

Aug 07, 2019
SELL
$14.71 - $19.79 $175,710 - $236,391
-11,945 Reduced 13.0%
79,928 $1.57 Million
Q1 2019

May 01, 2019
BUY
$13.73 - $16.87 $54,563 - $67,041
3,974 Added 4.52%
91,873 $1.52 Million
Q4 2018

Feb 04, 2019
BUY
$10.6 - $17.49 $219,398 - $362,008
20,698 Added 30.8%
87,899 $1.23 Million
Q3 2018

Oct 25, 2018
BUY
$16.65 - $21.85 $313,036 - $410,801
18,801 Added 38.85%
67,201 $1.18 Million
Q2 2018

Aug 02, 2018
BUY
$14.8 - $18.8 $220,771 - $280,439
14,917 Added 44.55%
48,400 $881,000
Q2 2018

Jul 25, 2018
SELL
$14.8 - $18.8 $104,236 - $132,408
-7,043 Reduced 17.38%
33,483 $512,000
Q1 2018

May 01, 2018
BUY
$14.5 - $23.4 $102,123 - $164,806
7,043 Added 21.03%
40,526 $760,000
Q4 2017

Feb 05, 2018
BUY
$13.5 - $16.65 $452,020 - $557,491
33,483
33,483 $512,000

Others Institutions Holding KURA

# of Institutions
181
Shares Held
80.2M
Call Options Held
148K
Put Options Held
63K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.31B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email